Could the Elixirr share price explode?

With its strong interim results, the Elixirr share price has surged. Christopher Ruane looks at whether it could keep moving up fast.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Consultancy group Elixirr (LSE: ELIX) has had an excellent run of late. The Elixirr share price has gone up by 183% in the past year. It increased 23% this week alone.

Here I consider whether Elixirr shares could keep climbing rapidly.

Elixirr: a business growing fast

The reason for the Elixirr share price growth this week is the company’s interim results, published on Monday. They showed strong business growth. Compared to the same period last year, revenues grew by 77%. Pre-tax profit showed an even more impressive increase, of 145%.

There is more to like about the company’s financial performance. The debt-free business has net cash of £21.1m. It also reported a “strong pipeline for the remainder of the year”, leading the company’s board to upgrade full-year revenue expectations for the second time.

So far, so good. There are shades here of the sort of growth seen at a company in my portfolio, S4 Capital, which has also upgraded its own expectations for the year multiple times.

The challenge of scaling consultancy

However, it’s worth noting that whereas S4 has a purely digital focus, Elixirr is using a more traditional consultancy business model. It styles itself as “The Challenger Consultancy”. But ultimately, consultancies rely on paying skilled professionals to win and deliver work. So even if a lot of the work is delivered digitally, I see inherent limitations to the scaleability of Elixirr’s business model.

Consider, for example, the company’s comments on part of its growth strategy in the interim results. Under the growth pillar “Stretching existing partners”,  the company noted that it “increased revenue per client-facing Partner in H1 21, while continuing to grow the Partner team”.

That reflects typical ways in which consultancies can grow revenues. They can get fee earners to bill more, hire more staff, or a combination of both. Elixirr seems to be doing this well, given its strong growth in the half. But there are inherent limitations to such an approach. Those include the ceiling on prices customers will accept, and the availability of the right talent pool. A consultancy model which relies on fee earners is inherently limited in how many customers it can serve without significantly adding to its cost base. That isn’t true in the same way in a digital business model.

The Elixirr share price and expectations

While the first half performance was excellent, in absolute terms the numbers are still fairly modest. Revenue was £24m and pre-tax profit came in at £6.4m.

The company has a market cap of £312m. Using the interim earnings, that equates to a prospective price-to-earnings ratio of around 24. I think that is high for any consultancy. A key part of what differentiates consultancies from competitors is their people. But they can simply walk out of the door any day of the week. Elixirr’s intellectual property, client relationships, and reputation give it some competitive advantage. But at its heart, a consultancy relies on retaining talent. That can be costly to do, eating into profits.

I am impressed by Elixirr’s growth rate. But I think the valuation looks full for a consulting business. Given the investor enthusiasm demonstrated this week, I do think further good news could lead to more dramatic increases in the Elixirr share price. But I won’t be buying.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Christopher Ruane owns shares in S4 Capital. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Number three written on white chat bubble on blue background
Investing Articles

Just released: the 3 best growth-focused stocks to consider buying in May [PREMIUM PICKS]

Our goal here is to highlight some of our past recommendations that we think are of particular interest today, due…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

With £1,000 to invest, should I buy growth stocks or income shares?

Dividend shares are a great source of passive income, but how close to retirement, should investors think about shifting away…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

Warren Buffett should buy this flagging FTSE 100 firm!

After giving $50bn to charity, Warren Buffett still has a $132bn fortune. Also, his company has $168bn to spend, so…

Read more »

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop
Investing For Beginners

I wish I’d known about this lucrative style of stock market investing 20 years ago

Research has shown that over the long term, this style of investing can generate returns in excess of those provided…

Read more »

Woman using laptop and working from home
Investing Articles

Is this growing UK fintech one of the best shares to buy now?

With revenues growing at 24% and income growing at 36%, Wise looks like one of the best shares to buy…

Read more »

Dividend Shares

Are Aviva shares one of the UK’s best investments today?

UK investors have been piling into Aviva shares recently. However, Edward Sheldon's wondering if he could get bigger returns elsewhere.

Read more »

Older couple walking in park
Investing Articles

10.2% dividend yield! 2 value shares to consider for a £1,530 passive income

Royston Wild explains why investing in these value shares could provide investors with significant passive income for years to come.

Read more »

man in shirt using computer and smiling while working in the office
Investing Articles

Nvidia and a FTSE 100 fund own a 10% stake in this $8 artificial intelligence (AI) stock

Ben McPoland explores Recursion Pharmaceuticals (NASDAQ:RXRX), an up-and-coming AI firm held by Cathie Wood, Nvidia and one FTSE 100 trust.

Read more »